Biden receives first dose of COVID vaccine, stressing its safety
Mr. Biden joins a growing list of public officials who have shared their experiences getting inoculated against COVID-19 as part of efforts to build public trust in its safety.
Watch CBS News
Mr. Biden joins a growing list of public officials who have shared their experiences getting inoculated against COVID-19 as part of efforts to build public trust in its safety.
New Jersey Governor Phil Murphy joins "CBS This Morning" to discuss news that the state will receive almost 100,000 fewer coronavirus vaccine doses than anticipated, as well as reaction to Congress' stimulus package.
Scientists are tracking a new coronavirus variant, as a CDC panel says Americans 75 and older and frontline essential workers should be next in line for vaccination. Biden Coronavirus Adviser Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, explains how these developments could affect vaccine rollout.
President-elect Joe Biden received his first dose of Pfizer's COVID-19 vaccine in front of television cameras in an effort to boost public confidence in the safety of the vaccine. Mr. Biden urged Americans to get the shot when they can, saying they have "nothing to worry about." Watch his remarks.
A new COVID-19 mutation has been identified in the United Kingdom, as vaccines by Pfizer and Moderna roll out both in the U.S. and the U.K. to frontline workers. Experts recommend people continue to observe safety precautions and limit travel as the country heads into the holidays. Emergency medicine physician Dr. Ron Elfenbein joins CBSN to discuss the latest on the coronavirus vaccine and the mutation of the virus now affecting the UK.
Vaccine distribution continues nationwide after the FDA authorized the second U.S. vaccine for emergency use. The first Moderna vaccination could happen as early as Monday morning. Correspondent Mola Lenghi reports from Long Island Jewish Medical Center in Queens, New York.
Workers began packaging boxes of the second COVID-19 vaccine authorized in the United States — and are expected to be given out starting Monday.
Bill Whitaker reports on the scientists and advances in biotechnology behind a COVID-19 vaccine that could help end the pandemic.
The FDA has issued emergency use authorization for Moderna's COVID-19 vaccine, the second vaccine to be approved in the U.S. The company will now ship out 6 million initial doses of the vaccine. Lana Zak reports.
The FDA could authorize emergency use of Moderna's coronavirus vaccine as early as today, which would make it the second vaccine available in U.S. CBS News' David Begnaud reports on the fight against the growing pandemic, and Dr. Annette Reboli, professor of medicine and dean of the Cooper Medical School of Rowan University, join CBSN to discuss the latest on efforts to roll out the vaccines.
Health care workers across the country are waiting for their hospital to receive the first round of Pfizer's coronavirus vaccine as COVID-19 surges. Meanwhile, the Food and Drug Administration is gearing up to approve emergency-use authorization for Moderna's vaccine. Dr. Kelechi Olejeme joins CBSN AM one day after receiving the Pfizer vaccine. She explained the differences between the two vaccines and how she felt following her inoculation.
The Food and Drug Administration could approve Moderna's coronavirus vaccine Friday, which means 6 million doses could be shipped around the country as soon as next week. CBS News correspondent David Begnaud and Dr. Bob Lahita, professor at New York Medical College, join CBSN to discuss the nation's worsening crisis and the new vaccine.
White House correspondent Ben Tracy joins "CBS This Morning" to discuss Vice President Mike Pence getting vaccinated on live TV, what message it sends and the other White House officials who are expected to get the vaccine.
At least six European countries have said flights will cease — if they haven't already — while France and Belgium have also banned train travel.
The first shipment of Moderna's COVID-19 vaccine has begun rolling out of a Memphis facility for nationwide distribution. Errol Barnett reports.
Dr. Frank Tamburrino shares his story of how he contracted the coronavirus and fought hard to survive. The virus sent him to the hospital where his family feared they wouldn't see him again. Dr. Tamburrino of New Jersey joins CBSN's Lana Zak to share his story.
Surgeon General Jerome Adams says the president has a "medical reason" for not getting the vaccine, since he was treated with antibodies in October.
CBS News' Mark Strassmann reports from Georgia on the nationwide surge in COVID-19 cases.
Former FDA commissioner Scott Gottlieb says the new coronavirus strain spreading in Europe is probably not more lethal than others, but that early data shows it’s easier to transmit.
The rollout for Pfizer's COVID-19 vaccination is now in full swing. Health care workers across the country were among the first Americans to receive the shot this week. This comes as deaths and cases continue to spike, with the U.S. recording thousands of new deaths each day. "Face the Nation" moderator Margaret Brennan joins CBSN's Lana Zak to discuss that and more.
The Moderna vaccine has become the second coronavirus vaccine authorized by the FDA, as the Pfizer vaccine continues to roll out throughout the U.S. The country is in desperate need of more relief from vaccines, as hospitalizations and deaths rise at disturbing rates. Dr. Henry Bernstein joins CBSN to discuss the vaccines and what needs to be done to improve the situation across the nation.
Missed the second half of the show? The latest on covid-19 vaccine and antibody treatment, cyber security attacks and the economic aid for the coronavirus relief bill.
Klain said there have been different messages coming from the White House, secretary of state and President Trump's Twitter feed.
Gottlieb said the new strain is "probably not more lethal" than existing variants of the coronavirus.
The following is a transcript of an interview with David Ricks, chairman and CEO of Eli Lilly and Company, that aired Sunday, December 20, 2020, on "Face the Nation."